Becton Dickinson and Co vs Invesco S&P 500 Momentum ETF — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Invesco S&P 500 Momentum ETF trades at $150. The key difference: Becton Dickinson and Co pays a 2.32% dividend while Invesco S&P 500 Momentum ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, Invesco S&P 500 Momentum ETF nearer its low. Which is the better fit depends on your goals.
| BDX | SPMO | |
|---|---|---|
Market Cap | $49.41B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $185.39 | $161.66 |
52-Week Low | $138.62 | $107.84 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | — |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →